α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
Open accessAbstract
Protein aggregation causes α-synuclein to switch from its physiological role to a pathological toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP synthase efficiency. Here, we report that aggregation of monomers generates beta sheet-rich oligomers that localise to the mitochondria in close proximity to several mitochondrial proteins including ATP synthase. Oligomeric α-synuclein impairs complex I-dependent respiration. Oligomers induce selective oxidation of the ATP synthase beta subunit and mitochondrial lipid peroxidation. These oxidation events increase the probability of permeability transition pore (PTP) opening, triggering mitochondrial swelling, and ultimately cell death. Notably, inhibition of oligomer-induced oxidation prevents the pathological induction of PTP. Inducible pluripotent stem cells (iPSC)-derived neurons bearing SNCA triplication, generate α-synuclein aggregates that interact with the ATP synthase and induce PTP opening, leading to neuronal death. This study shows how the transition of α-synuclein from its monomeric to oligomeric structure alters its functional consequences in Parkinson’s disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other in vitro studies revealed oligomeric α-synuclein induced mitochondrial dysfunction and neuronal death through multiple mechanisms.
“But other in vitro studies revealed that oligomeric α-synuclein induced mitochondrial dysfunction and neuronal death through multiple mechanisms.56,57”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620 · see citing works
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080 · see citing works
Role of mitochondrial <scp>ROS</scp> in the brain: from physiology to neurodegeneration
Angelova, P. R., & Abramov, A. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.12964 · Cited by 789 · see citing works
Self-citationParkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 58
- [1]Kruger R Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease Nat. Genet. 1998 18 106 108 10.1038/ng0298-106 9462735 · DOI · Paper page
- [2]Polymeropoulos MH Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease Science 1997 276 2045 2047 10.1126/science.276.5321.2045 9197268 · DOI · Paper page
- [3]Chartier-Harlin MC Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease Lancet 2004 364 1167 1169 10.1016/S0140-6736(04)17103-1 15451224 · DOI · Paper page
- [4]Singleton AB Alpha-synuclein locus triplication causes Parkinson’s disease Science 2003 302 841 10.1126/science.1090278 14593171 · DOI · Paper page
- [5]Mor DE Dopamine induces soluble alpha-synuclein oligomers and nigrostriatal degeneration Nat. Neurosci. 2017 20 1560 1568 10.1038/nn.4641 28920936 PMC5893155 · DOI
- [7]Cremades N Direct observation of the interconversion of normal and toxic forms of alpha-synuclein Cell 2012 149 1048 1059 10.1016/j.cell.2012.03.037 22632969 PMC3383996 · DOI
- [8]Deas E Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson’s disease Antioxid. Redox Signal. 2016 24 376 391 10.1089/ars.2015.6343 26564470 PMC4999647 · DOI
- [9]Angelova PR Calcium is a key factor in alpha-synuclein induced neurotoxicity J. Cell Sci. 2016 129 1792 1801 10.1242/jcs.180737 26989132 PMC4893653 · DOI
- [10]Ludtmann MH Monomeric alpha-synuclein exerts a physiological role on brain ATP synthase J. Neurosci. 2016 36 10510 10521 10.1523/JNEUROSCI.1659-16.2016 27733604 PMC5059426 · DOI
- [11]Horrocks MH Single-molecule imaging of individual amyloid protein aggregates in human biofluids ACS Chem. Neurosci. 2016 7 399 406 10.1021/acschemneuro.5b00324 26800462 PMC4800427 · DOI
- [12]Reeve AK Aggregated alpha-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons Cell Death Dis. 2015 6 e1820 10.1038/cddis.2015.166 26181201 PMC4650719 · DOI
- [13]Baev AY Elustondo PA Negoda A Pavlov EV Osmotic regulation of the mitochondrial permeability transition pore investigated by light scattering, fluorescence and electron microscopy techniques Anal. Biochem. 2017 2697 30290 30297 28693989
- [14]Oueslati A Ximerakis M Vekrellis K Protein transmission, seeding and degradation: key steps for alpha-synuclein prion-like propagation Exp. Neurobiol. 2014 23 324 336 10.5607/en.2014.23.4.324 25548532 PMC4276803 · DOI
- [15]Jungmann R Multiplexed 3D cellular super-resolution imaging with DNA-PAINT and Exchange-PAINT Nat. Methods 2014 11 313 318 10.1038/nmeth.2835 24487583 PMC4153392 · DOI
- [16]Abramov AY Scorziello A Duchen MR Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation J. Neurosci. 2007 27 1129 1138 10.1523/JNEUROSCI.4468-06.2007 17267568 PMC6673180 · DOI
- [17]Angelova PR Lipid peroxidation is essential for alpha-synuclein-induced cell death J. Neurochem. 2015 133 582 589 10.1111/jnc.13024 25580849 PMC4471127 · DOI
- [18]Trachootham D Lu W Ogasawara MA Nilsa RD Huang P Redox regulation of cell survival Antioxid. Redox Signal. 2008 10 1343 1374 10.1089/ars.2007.1957 18522489 PMC2932530 · DOI · Paper page
- [19]Cai Z Yan LJ Protein oxidative modifications: beneficial roles in disease and health J. Biochem. Pharmacol. Res. 2013 1 15 26 23662248 PMC3646577
- [20]Kim G Weiss SJ Levine RL Methionine oxidation and reduction in proteins Biochim. Biophys. Acta 2014 1840 901 905 10.1016/j.bbagen.2013.04.038 23648414 PMC3766491 · DOI · Paper page
- [21]Hardin SC Larue CT Oh MH Jain V Huber SC Coupling oxidative signals to protein phosphorylation via methionine oxidation in Arabidopsis Biochem. J. 2009 422 305 312 10.1042/BJ20090764 19527223 PMC2782308 · DOI
- [22]Fuchs J Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication Neurology 2007 68 916 922 10.1212/01.wnl.0000254458.17630.c5 17251522 · DOI
- [24]Abramov AY Duchen MR Actions of ionomycin, 4-BrA23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells Cell Calcium 2003 33 101 112 10.1016/S0143-4160(02)00203-8 12531186 · DOI
- [25]Zamaraeva MV Ionophoretic properties of ferutinin Cell Calcium 1997 22 235 241 10.1016/S0143-4160(97)90062-2 9481474 · DOI
- [26]Abramov AY Zamaraeva MV Hagelgans AI Azimov RR Krasilnikov OV Influence of plant terpenoids on the permeability of mitochondria and lipid bilayers Biochim. Biophys. Acta 2001 1512 98 110 10.1016/S0005-2736(01)00307-8 11334628 · DOI
- [27]Nakamura K Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein J. Biol. Chem. 2011 286 20710 20726 10.1074/jbc.M110.213538 21489994 PMC3121472 · DOI
- [28]Rostovtseva TK Alpha-synuclein shows high affinity interaction with voltage-dependent anion channel, suggesting mechanisms of mitochondrial regulation and toxicity in Parkinson disease J. Biol. Chem. 2015 290 18467 18477 10.1074/jbc.M115.641746 26055708 PMC4513106 · DOI
- [29]Chinta SJ Mallajosyula JK Rane A Andersen JK Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo Neurosci. Lett. 2010 486 235 239 10.1016/j.neulet.2010.09.061 20887775 PMC2967673 · DOI
- [30]Hsu LJ Alpha-synuclein promotes mitochondrial deficit and oxidative stress Am. J. Pathol. 2000 157 401 410 10.1016/S0002-9440(10)64553-1 10934145 PMC1850140 · DOI
- [31]Luth ES Stavrovskaya IG Bartels T Kristal BS Selkoe DJ Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction J. Biol. Chem. 2014 289 21490 21507 10.1074/jbc.M113.545749 24942732 PMC4118111 · DOI
- [32]Flierl A Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication PLoS ONE 2014 9 e112413 10.1371/journal.pone.0112413 25390032 PMC4229205 · DOI
- [33]Hunter DR Haworth RA Southard JH Relationship between configuration, function, and permeability in calcium-treated mitochondria J. Biol. Chem. 1976 251 5069 5077 134035
- [34]Brenner C Moulin M Physiological roles of the permeability transition pore Circ. Res. 2012 111 1237 1247 10.1161/CIRCRESAHA.112.265942 23065346 · DOI
- [35]Gandhi S Dopamine induced neurodegeneration in a PINK1 model of Parkinson’s disease PLoS ONE 2012 7 e37564 10.1371/journal.pone.0037564 22662171 PMC3360782 · DOI
- [36]Brustovetsky N Klingenberg M Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+ Biochemistry 1996 35 8483 8488 10.1021/bi960833v 8679608 · DOI
- [37]Halestrap AP What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 2009 46 821 831 10.1016/j.yjmcc.2009.02.021 19265700 · DOI
- [38]Lemasters JJ Theruvath TP Zhong Z Nieminen AL Mitochondrial calcium and the permeability transition in cell death Biochim. Biophys. Acta 2009 1787 1395 1401 10.1016/j.bbabio.2009.06.009 19576166 PMC2730424 · DOI
- [39]Morciano G Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury J. Mol. Cell. Cardiol. 2015 78 142 153 10.1016/j.yjmcc.2014.08.015 25172387 · DOI
- [40]Bernardi P Di LF Fogolari F Lippe G From ATP to PTP and back: a dual function for the mitochondrial ATP synthase Circ. Res. 2015 116 1850 1862 10.1161/CIRCRESAHA.115.306557 25999424 PMC4443805 · DOI
- [41]Giorgio V Dimers of mitochondrial ATP synthase form the permeability transition pore Proc. Natl. Acad. Sci. USA 2013 110 5887 5892 10.1073/pnas.1217823110 23530243 PMC3625323 · DOI
- [42]He J Carroll J Ding S Fearnley IM Walker JE Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase Proc. Natl. Acad. Sci. USA 2017 114 9086 9091 10.1073/pnas.1711201114 28784775 PMC5576841 · DOI · Paper page
- [43]He J Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase Proc. Natl. Acad. Sci. USA 2017 114 3409 3414 10.1073/pnas.1702357114 28289229 PMC5380099 · DOI · Paper page
- [44]Alavian KN An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore Proc. Natl. Acad. Sci. USA 2014 111 10580 10585 10.1073/pnas.1401591111 24979777 PMC4115574 · DOI
- [45]De Marchi E Bonora M Giorgi C Pinton P The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux Cell Calcium 2014 56 1 13 10.1016/j.ceca.2014.03.004 24755650 PMC4074345 · DOI
- [46]Elustondo PA Mitochondrial permeability transition pore induction is linked to formation of the complex of ATPase C-subunit, polyhydroxybutyrate and inorganic polyphosphate Cell Death Discov. 2016 2 16070 10.1038/cddiscovery.2016.70 27924223 PMC5137186 · DOI
- [47]Giorgio V Ca2+ binding to F-ATP synthase beta subunit triggers the mitochondrial permeability transition EMBO Rep. 2017 18 1065 1076 10.15252/embr.201643354 28507163 PMC5494526 · DOI
- [48]Allsop D Mayes J Moore S Masad A Tabner BJ Metal-dependent generation of reactive oxygen species from amyloid proteins implicated in neurodegenerative disease Biochem. Soc. Trans. 2008 36 1293 1298 10.1042/BST0361293 19021543 · DOI
- [49]Wang SB Murray CI Chung HS Van Eyk JE Redox regulation of mitochondrial ATP synthase Trends Cardiovasc. Med. 2013 23 14 18 10.1016/j.tcm.2012.08.005 23312134 PMC3936247 · DOI
- [51]Gomes FM BMP-SMAD signaling regulates lineage priming, but is dispensable for self-renewal in mouse embryonic stem cells Stem Cell Rep. 2016 6 85 94 10.1016/j.stemcr.2015.11.012 PMC4720007 26711875 · DOI
- [52]Baud A Multiplex high-throughput targeted proteomic assay to identify induced pluripotent stem cells Anal. Chem. 2017 89 2440 2448 10.1021/acs.analchem.6b04368 28192931 · DOI
- [54]Shi Y Kirwan P Smith J Robinson HP Livesey FJ Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses Nat. Neurosci. 2012 15 477 486 10.1038/nn.3041 22306606 PMC3882590 · DOI · Paper page
- [55]Baev AY Negoda A Abramov AY Modulation of mitochondrial ion transport by inorganic polyphosphate-essential role in mitochondrial permeability transition pore J. Bioenerg. Biomembr. 2017 49 49 55 10.1007/s10863-016-9650-3 26888154 PMC5331082 · DOI
- [56]Shevchenko A Tomas H Havlis J Olsen JV Mann M In-gel digestion for mass spectrometric characterization of proteins and proteomes Nat. Protoc. 2006 1 2856 2860 10.1038/nprot.2006.468 17406544 · DOI
- [57]Suzuki S Methionine sulfoxides in serum proteins as potential clinical biomarkers of oxidative stress Sci. Rep. 2016 6 38299 10.1038/srep38299 27929071 PMC5144094 · DOI
- [58]Vizcaíno, J. V. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res.44, D447–D456 (2016). PMC4702828 26527722
- [59]Schnitzbauer J Strauss MT Schlichthaerle T Schueder F Jungmann R Super-resolution microscopy with DNA-PAINT Nat. Protoc. 2017 12 1198 1228 10.1038/nprot.2017.024 28518172 · DOI · Paper page
- [61]Banterle N Bui KH Lemke EA Beck M Fourier ring correlation as a resolution criterion for super-resolution microscopy J. Struct. Biol. 2013 183 363 367 10.1016/j.jsb.2013.05.004 23684965 · DOI
- [62]Nieuwenhuizen RP Measuring image resolution in optical nanoscopy Nat. Methods 2013 10 557 562 10.1038/nmeth.2448 23624665 PMC4149789 · DOI
- [63]Janeczek AA PEGylated liposomes associate with Wnt3A protein and expand putative stem cells in human bone marrow populations Nanomedicine (Lond.) 2017 12 845 863 10.2217/nnm-2016-0386 28351228 · DOI
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724 · see citing works
Interaction of Mitochondrial Calcium and ROS in Neurodegeneration
Baev, A. Y., Vinokurov, A. Y., Novikova, I. N., Dremin, V. V., Potapova, E. V., & Abramov, A. Y. (2022) · Cells · doi:10.3390/cells11040706 · Cited by 162 · see citing works
Self-citationHong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells · doi:10.3390/cells9030740 · Cited by 133 · see citing works
Disease model organism for Parkinson disease: <i>Drosophila melanogaster</i>
Aryal, B., & Lee, Y. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.4.204 · Cited by 111 · see citing works
The mitochondrial permeability transition: Nexus of aging, disease and longevity
Rottenberg, H., & Hoek, J. B. (2021) · Cells · doi:10.3390/cells10010079 · Cited by 94 · see citing works
Calcium, Bioenergetics, and Parkinson’s Disease
Zampese, E., & Surmeier, D. J. (2020) · Cells · doi:10.3390/cells9092045 · Cited by 79 · see citing works
Esteras, N., Kundel, F., Amodeo, G. F., Pavlov, E. V., Klenerman, D., & Abramov, A. Y. (2021) · The FEBS Journal · doi:10.1111/febs.15340 · Cited by 78 · see citing works
Self-citationInterplay of mitochondrial calcium signalling and reactive oxygen species production in the brain
Angelova, P. R., & Abramov, A. Y. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240261 · Cited by 56 · see citing works
Self-citationAge-related Changes in the Energy of Human Mesenchymal Stem Cells
Barilani, M., Lovejoy, C., Piras, R., Abramov, A. Y., Lazzari, L., & Angelova, P. R. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30638 · Cited by 31 · see citing works
Self-citation
- Authors
- Ludtmann, M. H. R., Angelova, P. R., Horrocks, M. H., Choi, M. L., Rodrigues, M., Baev, A. Y., Berezhnov, A. V., Yao, Z., Little, D., Banushi, B., Al-Menhali, A. S., Ranasinghe, R. T., Whiten, D. R., Yapom, R., Dolt, K. S., Devine, M. J., Gissen, P., Kunath, T., Jaganjac, M., Pavlov, E. V., Klenerman, D., Abramov, A. Y., & Gandhi, S.
- Affiliations
- Royal Veterinary College (GB)
- UCL Queen Square Institute of Neurology (GB)
- University of Cambridge (GB)
- The Francis Crick Institute (GB)
- Russian Academy of Sciences (RU)
- MRC Laboratory for Molecular Cell Biology (GB)
- MRC Centre for Regenerative Medicine (GB)
- Anti-Doping Laboratory (QA)
- New York University (US)
- Corresponding author
- Abramov, Andrey Y.
- Gandhi, Sonia
- ORCID
- Ludtmann, Marthe H. R.
- Angelova, Plamena R.
- Horrocks, Mathew H.
- Choi, Minee L.
- Rodrigues, Margarida
- Baev, Artyom Y.
- Berezhnov, Alexey V.
- Yao, Zhi
- Little, Daniel
- Banushi, Blerida
- Ranasinghe, Rohan T.
- Whiten, Daniel R.
- Dolt, Karamjit Singh
- Devine, Michael J.
- Gissen, Paul
- Kunath, Tilo
- Jaganjac, Morana
- Pavlov, Evgeny V.
- Klenerman, David
- Abramov, Andrey Y.
- Gandhi, Sonia
- Venue
- Nature Communications
- Published
- 2018-06-12
- Volume
- 9
- Issue
- 1
- Pages
- 2293-2293
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5997668
- OpenAlex
- W2805954533
- Cited by
- 513
- References
- 4
- Citations by year
- 2026: 45 · 2025: 63 · 2024: 68 · 2023: 49 · 2022: 69 · 2021: 71 · 2020: 81 · 2019: 57 · 2018: 10
- FWCI
- 37.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- American Heart Association (16GRNT27260229)
- Wellcome Trust (100172/Z/12/Z, 100172/Z/12A, 106713/Z/14/Z)
- European Federation of Pharmaceutical Industries and Associations
- Paul G. Allen Frontiers Group
- National Institute for Health and Care Research (14/21/45)
- Parkinson's UK (F-0902)
- Academy of Medical Sciences (AMS-SGCL5-Gandhi)
- European Commission (2014‐2020, 2007–2013, 115439)
- University College London Hospitals NHS Foundation Trust
- Innovative Medicines Initiative (115439)
- Royal Veterinary College
- Medical Research Council (MR/J012831/1)
- Christ's College, University of Cambridge
- NIHR Great Ormond Street Hospital Biomedical Research Centre
- National Institute of General Medical Sciences (R01GM115570)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein oligomers, ATP synthase, mitochondrial permeability transition pore, Parkinson's disease, protein aggregation, lipid peroxidation, mitochondrial swelling, neuronal cell death, SNCA triplication, iPSC-derived neurons, mitochondrial dysfunction
- MeSH terms
- Mitochondrial Permeability Transition Pore, Animals, Humans, Mitochondria, Neurons, Oxidation-Reduction, Parkinson Disease, Permeability, Lipid Peroxidation, Rats, Sprague-Dawley, Reactive Oxygen Species, Patch-Clamp Techniques, Coculture Techniques, Mitochondrial Proton-Translocating ATPases, Mitochondrial Membrane Transport Proteins, Proteomics, Rats, alpha-Synuclein, Embryonic Stem Cells, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review